Drug recall

TRYX Absorbable Antibacterial Envelope Product Usage: Indicated for stabilization of implanted pacemakers…

FDA recall event 74672 · Class II · TYRX Inc.

Key facts

Event ID 74672
Recall numbers Z-2539-2016, Z-2540-2016, Z-2541-2016
Recalling firm TYRX Inc.
Product type Devices
Products TRYX Absorbable Antibacterial Envelope Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD), TRYX Antibacterial Envelope Rx Only Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD), TRYX Neuro Absorbable Antibacterial Envelope Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD)
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall TRYX products are being recalled since the processes of spaying, welding, drying oven and polymer were not adequately validated.
Initiation date Jun 29, 2016
Report date Aug 24, 2016
Termination date Dec 12, 2017
City Monmouth Junction
State NJ
Country United States
FEI number 3005619263

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls